Found: 10
Select item for more details and to access through your institution.
Authors' response to letter to editor.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 305, doi. 10.1007/s10928-024-09927-6
- By:
- Publication type:
- Article
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
ChatGPT and Gemini large language models for pharmacometrics with NONMEM: comment.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 303, doi. 10.1007/s10928-024-09926-7
- By:
- Publication type:
- Article
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Note on importance of correct stoichiometric assumptions for modeling of monoclonal antibodies.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 307, doi. 10.1007/s10928-024-09918-7
- By:
- Publication type:
- Article
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 385, doi. 10.1007/s10928-024-09914-x
- By:
- Publication type:
- Article
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 335, doi. 10.1007/s10928-024-09913-y
- By:
- Publication type:
- Article
Docetaxel, cyclophosphamide, and epirubicin: application of PBPK modeling to gain new insights for drug-drug interactions.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 367, doi. 10.1007/s10928-024-09912-z
- By:
- Publication type:
- Article
On inductive biases for the robust and interpretable prediction of drug concentrations using deep compartment models.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 355, doi. 10.1007/s10928-024-09906-x
- By:
- Publication type:
- Article
Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 4, p. 319, doi. 10.1007/s10928-024-09903-0
- By:
- Publication type:
- Article